Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Julia B. Zella"'
Autor:
Julia B. Zella, Brenda Niu, Nicole Thomas, Kara K. Hoppe, Melissa Zernick, Ali N. Lohr, Thomas C. Havighurst, Heather M. Johnson, KyungMann Kim, Makeba Williams
Publikováno v:
American Journal of Obstetrics and Gynecology. 223:585-588
Autor:
Julia B. Zella, Margaret Clagett-Dame, Raymond D. Buck, Lori A. Plum, William J. Blaser, Ravi Thadhani, Hector F. DeLuca, Danielle C. Knutson
Publikováno v:
American Journal of Nephrology. 45:40-48
Background: Vitamin D analogs and calcimimetics are used to manage secondary hyperparathyroidism (SHPT) in dialysis patients. DP001 is an oral vitamin D analog that suppresses parathyroid hormone (PTH) in uremic rats, osteopenic women, and hemodialys
Autor:
Kara K. Hoppe, Julia B. Zella, Makeba Williams, Thomas C. Havighurst, Anna Drewry, Nicole Thomas, Heather M. Johnson, KyungMann Kim
Publikováno v:
Pregnancy hypertension. 15
Objective Investigate feasibility of telehealth with remote blood pressure monitoring for management of hypertension in postpartum women at risk of severe hypertension after hospital discharge. Methods In a single-center, prospective single-cohort fe
Autor:
Julia B. Zella, Kris Fedenia, Kyunmann Kim, Nicole Thomas, Thomas C. Havighurst, Kara K. Hoppe, Melissa Zernick, Heather M. Johnson, Ali N. Lohr, Dinesh M. Shah
Publikováno v:
American Journal of Obstetrics and Gynecology. 220:S303-S304
Publikováno v:
Hypertension. 70
Background: Postpartum hypertension is a leading indication for hospital readmission and maternal mortality. Objective: To conduct a pilot intervention to establish the feasibility of telehealth monitoring/treatment after hospital discharge for women
Autor:
Hao Yan, Patricia Fernández-Llama, Robert H. Christenson, David R. Plowchalk, David K. Packham, Xiaofang Yu, David B. Kingsmore, He Zhang, Joachim H. Ix, Cristina Esteva-Font, Michael W. Steffes, Yi Fang, Samuel A. Silver, Lori A. Plum, Maurizio Postorino, Jade J. Wong-You-Cheong, Jonathan G. Fox, Ziv Harel, Francesco U.S. Mattace-Raso, Ying Hang, Scott A. Reisman, Colin J. Meyer, Sokratis Stoumpos, Thomas C. Dowling, Marisa Battistella, Julia B. Zella, Hui Zhang, Xiaoxiao Yang, Francesca Mallamaci, Elena Guillén-Gómez, Stephen L. Seliger, J.M. Díaz, José Ballarín, Emma Aitken, Tongqiang Liu, David G. Warnock, George L. Bakris, Robert M. Richardson, Luis Guirado, Matthew R. Weir, Nosratola D. Vaziri, C Facundo, Graziella D'Arrigo, Hector F. DeLuca, Claudia Torino, Megan O'Grady, Laurence S. Magder, Zhaohui Ni, Kathryn K. Stevens, Ayse L. Mindikoglu, Shaopeng Liu, Jan L.C.M. van Saase, Marc Clancy, Giovanni Tripepi, Jiaqi Qian, Melanie P. Chin, Druckerei Stückle, Xiaoqiang Ding, Wei Fang, Emily C. Charlesworth, Peter A. McCullough, Margaret Clagett-Dame, Carmine Zoccali, Satz Mengensatzproduktion, William R. Hutson, Keith W. Ward, Rocco Tripepi, Colin C. Geddes, Aiwu Lin, Elisabet Ars, Jeffrey Perl, Michael Potochoiba, Madhumathi Rao, Jieru Cai, Bingying Zhang, Jiaying Huang, Andrew G. Bostom, Peter G. Linde
Publikováno v:
American Journal of Nephrology. 39:I-VI
Autor:
Hector F. DeLuca, Lori A. Plum, Margaret Clagett-Dame, Michael Potochoiba, Julia B. Zella, David R. Plowchalk
Publikováno v:
American Journal of Nephrology. 39:476-483
Background: The use of 1α-hydroxylated vitamin D therapy to control secondary hyperparathyroidism in renal failure patients has been a success story, culminating with the demonstration of increased life expectancy in patients treated with these comp
Publikováno v:
Obstetrics & Gynecology. 131:135S-136S
Autor:
Richa Pandey, Julia B. Zella, Margaret Clagett-Dame, Daniel W. Coyne, Hector F. DeLuca, Lori A. Plum
Publikováno v:
American journal of nephrology. 43(3)
Background: Use of existing therapies for secondary hyperparathyroidism (SHPT), such as calcitriol or paricalcitol, is frequently limited by the development of hypercalcemia. 2-Methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 (2MD; DP001) is a novel
Autor:
Julia B. Zella, Lorraine A. Fitzpatrick, Lori A. Plum, Neil Binkley, Margaret Clagett-Dame, Xiaohong Ma, Hector F. DeLuca
Publikováno v:
Osteoporosis International. 17:704-715
2-Methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 (2MD) is a new analog of 1alpha,25-dihydroxyvitamin D3 (1,25-(OH)2D3) that has unique properties (distinct from 1alpha,25-dihydroxyvitamin D3) in stimulating osteoblasts to form bone in culture.